Qvar Versus Clenil, a General Practice Research Database Study
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study will compare the absolute and relative effectiveness of asthma management in
patients on inhaled corticosteroid (ICS) maintenance therapy as either extra-fine-particle or
larger-particle formulation beclomethasone dipropionate (BDP) via metered-dose inhalers
(MDIs) using the propellant hydrofluoroalkane propellant (HFA-BDP), namely Qvar® MDI compared
with Clenil® MDI.
Details
Lead Sponsor:
Research in Real-Life Ltd
Collaborators:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries